share_log

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga ·  Feb 20 05:30

Gainers

  • Trxade Health (NASDAQ:MEDS) stock rose 105.3% to $8.5 during Monday's after-market session. The company's market cap stands at $10.2 million.
  • Iovance Biotherapeutics (NASDAQ:IOVA) shares moved upwards by 32.78% to $12.15. The company's market cap stands at $3.1 billion.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) shares moved upwards by 13.29% to $0.37. The company's market cap stands at $4.3 million.
  • Delcath Systems (NASDAQ:DCTH) shares increased by 9.92% to $4.84. The market value of their outstanding shares is at $106.6 million.
  • Dyadic International (NASDAQ:DYAI) shares moved upwards by 9.84% to $1.45. The company's market cap stands at $41.7 million.
  • NexImmune (NASDAQ:NEXI) stock increased by 8.9% to $8.56. The company's market cap stands at $11.1 million.

Losers

  • Universe Pharmaceuticals (NASDAQ:UPC) stock decreased by 27.6% to $1.78 during Monday's after-market session. The market value of their outstanding shares is at $6.4 million.
  • Sientra (NASDAQ:SIEN) stock decreased by 15.9% to $0.26. The market value of their outstanding shares is at $3.0 million.
  • Femasys (NASDAQ:FEMY) stock declined by 12.0% to $1.1. The company's market cap stands at $23.8 million.
  • Nexalin Technology (NASDAQ:NXL) stock decreased by 7.86% to $0.34. The market value of their outstanding shares is at $2.4 million.
  • Orgenesis (NASDAQ:ORGS) stock declined by 7.61% to $0.37. The company's market cap stands at $11.8 million.
  • Lucid Diagnostics (NASDAQ:LUCD) stock declined by 7.36% to $1.26. The company's market cap stands at $54.0 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment